IFI-204 Activators are a group of chemical compounds that indirectly enhance the functional activity of IFI-204, a protein involved in immune response and antiviral mechanisms. Compounds such as Interferon-alpha and Interferon-beta work by activating the JAK-STAT signaling pathway, leading to the upregulation of immune response genes, including IFI-204. These interferons are critical in enhancing the expression of IFI-204, playing a pivotal role in antiviral responses. Other compounds like Resveratrol, Curcumin, and (-)-Epigallocatechin Gallate modulate various signaling pathways that can influence the activity of IFI-204. Resveratrol, through its action on sirtuin and AMPK pathways, and Curcumin, via its broad effects on cellular signaling, could potentially lead to enhanced regulation of IFI-204 in immune response mechanisms. (-)-Epigallocatechin Gallate, as a polyphenol, could influence cellular metabolism and immune responses, thereby potentially modulating IFI-204 activity.
Additionally, compounds targeting epigenetic regulators and signaling pathways, such as JQ1, PD 0325901, 5-Azacytidine, and Sodium Butyrate, could indirectly enhance IFI-204 activity. JQ1, by influencing chromatin remodeling, and 5-Azacytidine, through its action as a DNA methyltransferase inhibitor, might alter the expression patterns of genes including IFI-204. Sodium Butyrate, as a histone deacetylase inhibitor, could also affect the regulation of genes involved in the immune response. Furthermore, inhibitors like BAY 11-7082, LY 294002, and SB 203580, which target NF-κB, PI3K/AKT, and p38 MAPK pathways, respectively, might modulate signaling pathways that impact IFI-204 expression and function. These diverse activators highlight the intricate network of signaling pathways and epigenetic mechanisms that regulate the activity of IFI-204, emphasizing its importance in immune and stress response pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could enhance IFI-204 activity by modulating sirtuin and AMPK pathways, which might influence cellular stress responses and potentially upregulate IFI-204 in certain contexts. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may influence IFI-204 activity by affecting various cellular signaling pathways, potentially leading to enhanced regulation of IFI-204 in immune response mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate, a polyphenol, could potentially enhance IFI-204 activity by modulating signaling pathways involved in cellular metabolism and immune responses. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1, a BET bromodomain inhibitor, might enhance IFI-204 activity by influencing chromatin remodeling and gene expression patterns, potentially affecting the expression of IFI-204. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, might enhance IFI-204 expression by altering epigenetic marks, leading to changes in the gene expression profile, including IFI-204. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate, a histone deacetylase inhibitor, could potentially enhance IFI-204 activity by affecting gene expression patterns, including the regulation of genes involved in the immune response. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082, a NF-κB inhibitor, might influence IFI-204 activity by modulating NF-κB signaling, potentially impacting the expression of IFI-204 in immune and inflammatory responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002, a PI3K inhibitor, could indirectly enhance IFI-204 activity by affecting PI3K/AKT pathway signaling, potentially influencing the regulation of IFI-204. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580, a p38 MAPK inhibitor, might shift signaling towards pathways involving IFI-204, potentially enhancing its activity in immune and stress response pathways. | ||||||